Ketanserin tartrate

This classification denotes a serotonin antagonist with the molecular formula C22H22FN3O3.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 645498QK7H, chemically known as 2,4(1h,3h)-quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1) but more generally known as ketanserin tartrate, which bears US NIH Compound Identifier 135348. European Medicines Agency schedules Ketanserin tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02831MIG. Most nations, for tariff and trade purposes, schedule ketanserin tartrate under HS 29335995 and SITC 51576. As of Q4 2014, KETANSERIN TARTRATE remains US FDA's Preferred Term for this commodity. Ketanserin tartrate bears US NLM identifiers UMLS ID C1517662 and NCI Concept Code C2036. SMILES: C1CCC2C(C1)C(=O)N(C(=O)[NH]2)CCN3CCC(CC3)C(=O)C4CCC(CC4)F.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.